|
Validation of Standardized Questionnaires Evaluating Symptoms of
Depression in Rheumatoid Arthritis Patients: Approaches to Screening
for a Frequent Yet Underrated Challenge.Englbrecht M, Alten R, Aringer
M, Baerwald CG, Burkhardt H, Eby N, Fliedner G, Gauger B, Henkemeier
U, Hofmann MW, Kleinert S, Kneitz C, Krueger K, Pohl C, Roske AE,
Schett G, Schmalzing M, Tausche AK, Peter Tony H, Wendler J. Arthritis
Care Res (Hoboken). 2017 Jan;69(1):58-66. doi: 10.1002/acr.23002.
|
|
Antimodified protein antibody response pattern influences the risk for
disease relapse in patients with rheumatoid arthritis tapering disease
modifying antirheumatic drugs. Figueiredo CP, Bang H, Cobra JF,
Englbrecht M, Hueber AJ, Haschka J, Manger B, Kleyer A, Reiser M,
Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M,
Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz
HM, Nuesslein H, Alten R, Henes J, Krueger K, Rech J, Schett G. Ann
Rheum Dis. 2017 Feb;76(2):399-407. doi:
10.1136/annrheumdis-2016-209297. Epub 2016 Jun 20
|
|
[Disease-modifying antirheumatic drugs in rheumatoid arthritis
patients with a history of colorectal cancer]. Kleinert S, Waldner M,
Wendler J, Kunzmann V. Z Rheumatol. 2016 Feb;75(1):41-6
|
|
Prediction of disease relapses by multibiomarker disease activity and
autoantibody status in patients with rheumatoid arthritis on tapering
DMARD treatment. Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J,
Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP,
Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M,
Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H,
Alten R, Henes J, Krueger K, Schett G. Ann Rheum Dis. 2016
Sep;75(9):1637-44. doi: 10.1136/annrheumdis-2015-207900. Epub 2015 Oct
19
|
|
Relapse rates in patients with rheumatoid arthritis in stable
remission tapering or stopping antirheumatic therapy: interim results
from the prospective randomised controlled RETRO study. Haschka J,
Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M, Finzel S, Tony
HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W,
Schmitt-Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM,
Nuesslein H, Alten R, Demary W, Henes J, Schett G, Rech J. Ann Rheum
Dis. 2016 Jan;75(1):45-51. doi: 10.1136/annrheumdis-2014-206439. Epub
2015 Feb 6
|
|
Rituximab in patients with rheumatoid arthritis in routine practice
(GERINIS): six-year results from a prospective, multicentre,
non-interventional study in 2,484 patients. Wendler J, Burmester GR,
Sörensen H, Krause A, Richter C, Tony HP, Rubbert-Roth A,
Bartz-Bazzanella P, Wassenberg S, Haug-Rost I, Dörner T. Arthritis Res
Ther. 2014 Mar 26;16(2):R80. doi: 10.1186/ar4521
|
|
Gustatory and olfactory function in patients with granulomatosis with
polyangiitis (Wegener's). Proft F, Steinbach S, Dechant C, Witt M,
Reindl C, Schulz S, Vielhauer V, Hilge R, Laubender RP, Manger K,
Nüsslein H, Wendler J, Schuch F, Schulze-Koops H, Grunke M. Scand J
Rheumatol. 2014;43(6):512-8. doi: 10.3109/03009742.2014.915056. Epub
2014 Sep 10.
|
|
Self-ratings of higher olfactory acuity contrast with reduced
olfactory test results of fibromyalgia patients. Lötsch J, Kraetsch
HG, Wendler J, Hummel T. Int J Psychophysiol. 2012 Nov;86(2):182-6.
doi: 10.1016/j.ijpsycho.2012.09.003. Epub 2012 Sep 15.
|
|
Is treat to target compatible with health insurance and health
insurance funds? Wendler J, Edelmann E Z Rheumatol. 2012
Oct;71(8):643-8.
|
|
Strategies for improved healthcare of people with the endemic disease
rheumatism exemplified by rheumatoid arthritis. Kalden JR, Burkhardt
H, Buss B, Donhauser-Gruber U, Erstling U, Gromnica-Ihle E, Karberg K,
Karger T, Kneitz CH, Krause A, Krüger K, Lorenz HM, Müller-Ladner U,
Rubbert-Roth A, Steffens-Korbanka P, Tony HP, Wendler J, Wollenhaupt
J, Burmester G. Z Rheumatol. 2011 Oct;70(8):641-50
|
|
Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to
susceptibility to psoriatic arthritis in German patients. Hüffmeier U,
Estivill X, Riveira-Munoz E, Traupe H, Wendler J, Lohmann J, Böhm B,
Burkhardt H, Reis A. Ann Rheum Dis. 2010 May;69(5):876-8. doi:
10.1136/ard.2009.108951. Epub 2009 May 12.
|
|
Genetic variants of the IL-23R pathway: association with psoriatic
arthritis and psoriasis vulgaris, but no specific risk factor for
arthritis. Hüffmeier U, Lascorz J, Böhm B, Lohmann J, Wendler J,
Mössner R, Reich K, Traupe H, Kurrat W, Burkhardt H, Reis A. J Invest
Dermatol. 2009 Feb;129(2):355-8. doi: 10.1038/jid.2008.233. Epub 2008
Sep 18.
|
|
Loss-of-function variants of the filaggrin gene are not major
susceptibility factors for psoriasis vulgaris or psoriatic arthritis
in German patients. Hüffmeier U, Traupe H, Oji V, Lascorz J, Ständer
M, Lohmann J, Wendler J, Burkhardt H, Reis A. J Invest Dermatol. 2007
Jun;127(6):1367-70. Epub 2007 Jan 25.
|
|
TNF polymorphisms in psoriasis: association of psoriatic arthritis
with the promoter polymorphism TNF*-857 independent of the PSORS1 risk
allele. Reich K, Hüffmeier U, König IR, Lascorz J, Lohmann J, Wendler
J, Traupe H, Mössner R, Reis A, Burkhardt H. Arthritis Rheum. 2007
Jun;56(6):2056-64.
|
|
MHC class II expression on myeloid cells inversely correlates with
disease progression in early rheumatoid arthritis. Mueller RB,
Skapenko A, Wendler J, Schuch F, Kalden JR, Schulze-Koops H.
Rheumatology (Oxford). 2007 Jun;46(6):931-3. Epub 2007 Mar 23.
|
|
Lack of genetic association of the interleukin-4 receptor
single-nucleotide polymorphisms I50V and Q551R with erosive disease in
psoriatic arthritis. Lascorz J, Hüffmeier U, Schulze-Koops H, Skapenko
A, Reis A, Lohmann J, Wendler J, Traupe H, Küster W, Burkhardt H.
Arthritis Rheum. 2006 Dec;54(12):4023-4.
|
|
Association of the IL4R single-nucleotide polymorphism I50V with
rapidly erosive rheumatoid arthritis. Prots I, Skapenko A, Wendler J,
Mattyasovszky S, Yoné CL, Spriewald B, Burkhardt H, Rau R, Kalden JR,
Lipsky PE, Schulze-Koops H. Arthritis Rheum. 2006 May;54(5):1491-500.
|
|
Male restricted genetic association of variant R620W in PTPN22 with
psoriatic arthritis. Hüffmeier U, Reis A, Steffens M, Lascorz J, Böhm
B, Lohmann J, Wendler J, Traupe H, Küster W, Wienker TF, Burkhardt H.
J Invest Dermatol. 2006 Apr;126(4):932-5.
|
|
Safety of 15-deoxyspergualin in the treatment of glomerulonephritis
associated with active systemic lupus erythematosus. Lorenz HM, Grunke
M, Wendler J, Heinzel PA, Kalden JR. Ann Rheum Dis. 2005
Oct;64(10):1517-9
|
|
Regulation of myeloid cell function and major histocompatibility
complex class II expression by tumor necrosis factor. Mueller RB,
Skapenko A, Grunke M, Wendler J, Stuhlmuller B, Kalden JR,
Schulze-Koops H. Arthritis Rheum. 2005 Feb;52(2):451-60.
|
|
Lack of evidence for genetic association to RUNX1 binding site at
PSORS2 in different German psoriasis cohorts. Hüffmeier U1, Traupe H,
Burkhardt H, Schürmeier-Horst F, Lascorz J, Böhm B, Lohmann J, Ständer
M, Wendler J, Kelsch R, Baumann C, Küster W, Wienker TF, Reis A. J
Invest Dermatol. 2005 Jan;124(1):107-10.
|
|
Open-label study of infliximab treatment for psoriatic arthritis:
clinical and magnetic resonance imaging measurements of reduction of
inflammation. Antoni C, Dechant C, Hanns-Martin Lorenz PD, Wendler J,
Ogilvie A, Lueftl M, Kalden-Nemeth D, Kalden JR, Manger B. Eur J
Immunol. 2002 May;32(5):1253-63.
|
|
Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes
from patients with systemic lupus erythematosus leads to accelerated
apoptosis. Lorenz HM1, Grünke M, Hieronymus T, Winkler S, Blank N,
Rascu A, Wendler J, Geiler T, Kalden JR. Arthritis Rheum. 2002 Oct
15;47(5):506-12
|
|
Multivariate analysis of factors influencing the effect of
radiosynovectomy. Farahati J, Schulz G, Wendler J, Körber C, Geling M,
Kenn W, Schmeider P, Reidemeister C, Reiners C. Nuklearmedizin. 2002
Apr;41(2):114-9
|
|
Patients with rheumatoid arthritis adapt differently to repetitive
painful stimuli compared to healthy controls. Wendler J, Hummel T,
Reissinger M, Manger B, Pauli E, Kalden JR, Kobal G. J Clin Neurosci.
2001 May;8(3):272-7.
|
|
Peripheral and central nervous changes in patients with rheumatoid
arthritis in response to repetitive painful stimulation. Hummel T,
Schiessl C, Wendler J, Kobal G. Int J Psychophysiol. 2000
Aug;37(2):177-83.
|
|
Altered memory T cell differentiation in patients with early
rheumatoid arthritis. Skapenko A, Wendler J, Lipsky PE, Kalden JR,
Schulze-Koops H. J Immunol. 1999 Jul 1;163(1):491-9.
|
|
Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid
synovial membrane: TNF receptors are localized preferentially in the
lining layer; TNF-alpha is distributed mainly in the vicinity of TNF
receptors in the deeper layers. Alsalameh S, Winter K, Al-Ward R,
Wendler J, Kalden JR, Kinne RW. Scand J Immunol. 1999
Mar;49(3):278-85.
|
|
Peripheral electrophysiological responses decrease in response to
repetitive painful stimulation of the human nasal mucosa. Hummel T,
Schiessl C, Wendler J, Kobal G. Neurosci Lett. 1996 Jul
5;212(1):37-40.
|
|
Somatostatin receptor expression in the thyroid demonstrated with
111In-octreotide scintigraphy. Becker W, Schrell U, Buchfelder M,
Hensen J, Wendler J, Gramatzki M, Wolf F. Nuklearmedizin. 1995
Jun;34(3):100-3.
|
|
67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in
the staging of B-cell non-Hodgkin's lymphoma. Becker WS, Behr TM,
Cumme F, Rössler W, Wendler J, Kern PM, Gramatzki M, Kalden JR,
Goldenberg DM, Wolf FG. Cancer Res. 1995 Dec 1;55(23
Suppl):5771s-5773s. Interleukin-6 production in B-cell neoplasias and
Castleman's disease: evidence for an additional paracrine loop. Burger
R, Wendler J, Antoni K, Helm G, Kalden JR, Gramatzki M. Ann Hematol.
1994 Jul;69(1):25-31.
|
|
Search for anti-idiotypic antibodies in sera of renal transplant
recipients. Daniel V, Wendler J, Opelz G. Transplant Proc. 1987
Feb;19(1 Pt 1):758-61
|
